Eli Lilly and Company (LLY)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 41.11
   
  • Change Today:
    $-0.05
  • 52 Week High: $41.80
  • 52 Week Low: $34.49
  • Currency: US Dollars
  • Shares Issued: 1,160.42m
  • Volume: 4,076,176
  • Market Cap: $47,705m
  • RiskGrade: 62
  • Beta: 0.55

LLY Overview

Founded in 1876, Eli Lilly is now a leading company involved in the discovery, development, manufacture and sale of pharmaceutical products. Headquartered in Indianapolis, the group's extensive portfolio of pharmaceutical products encompasses numerous areas, including neuroscience, endocrinology, oncology, animal health and other products for livestock and poultry, cardiovascular and anti-infectives. The company employs more than 43,000 people worldwide and sells its products in approximately 140 countries.

1 Day Chart (25-05-2012)

6 Month Chart

Financials

Latest F'cast
Div Yield 4.8%
Div Cover 2.0
Op Mrgn 22.0%
ROCE 34.7%
Latest F'cast
P/E 10.5
PEG n/a
Pr/Revenue 2.0
Pr/Book 3.5
Latest F'cast
Revenue 5.2%
PBT -18.0%
EPS -14.8%
DPS n/a

LLY Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 18,633.50 3,876.80 271.00¢ 19.7 1.8 +11% 175.00¢ 3.3%
31-Dec-08 20,371.90 (1,307.60) (189.00)¢ n/a n/a n/a 190.00¢ 4.7%
31-Dec-09 21,836.00 5,357.80 394.00¢ 9.1 n/a n/a 196.00¢ 5.5%
31-Dec-10 23,076.00 6,525.20 458.00¢ 7.7 0.5 +16% 196.00¢ 5.6%
31-Dec-11 24,286.50 5,349.50 390.00¢ 10.7 n/a -15% 196.00¢ 4.7%

LLY Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 22,662.23 4,637.35 328.41¢ 12.5 n/a -16% 195.25¢ 4.7%
31-Dec-13 23,180.03 5,275.72 368.79¢ 11.1 0.9 +12% 195.18¢ 4.7%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

LLY ShareCast News

US close: Markets recover from rough start 05-Jan-2012 ShareCast
US midday: Stocks recover despite retailers' woes 05-Jan-2012 ShareCast
Second quarter earnings by Eli Lilly fall as exp... 21-Jul-2011 ShareCast

LLY Top Newspaper Links

Patents Ending, Eli Lilly Chases New Drugs 01-Oct-2010 New York Times
Botox maker to pay $600M to resolve federal inve... 02-Sep-2010 USA Today
Eli Lilly posts 3rd-quarter profit but analysts ... 22-Oct-2009 Chicago Tribune

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

LLY Market Data

Currency US Dollars
Share Price $ 41.11
Change Today $ -0.05
% Change -0.12 %
52 Week High $41.80
52 Week Low $34.49
Volume 4,076,176
Shares Issued 1,160.42m
Market Cap $47,705m
Beta 0.55
RiskGrade 62

What The Brokers Say

Strong Buy 2
Buy 1
Neutral 18
Sell 1
Strong Sell 2
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-May-2012

Time Volume / Share Price
16:24 199,482 @ $41.11
16:15 634 @ $41.12
16:15 100 @ $41.12
16:15 135 @ $41.12
16:14 100 @ $41.11

Top of Page